METATYROSINE IN THE TREATMENT OF PARKINSONISM
- 16 September 1972
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 300 (7777), 605
- https://doi.org/10.1016/s0140-6736(72)92006-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Protection of the Neostriatal Dopamine Stores against Reserpine by Local Treatment with MetatyramineActa Pharmacologica et Toxicologica, 2009
- LONGEVITY AND CAUSES OF DEATH IN MALE ATHLETIC CHAMPIONSThe Lancet, 1971
- Therapeutic Implications in Parkinsonism of m-Tyramine Formation from L-Dopa in ManNature, 1971
- Metatyrosine as a tool for selective protection of catecholamine stores against reserpineEuropean Journal of Pharmacology, 1967
- The effect of L-3, 4-dihydroxyphenylalanine and DL-5- -hydroxytryptophan on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamineLife Sciences, 1964
- Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-ParkinsonismusArchiv Fur Psychiatrie Und Nervenkrankheiten, 1964
- An Investigation into the Longevity of Cambridge SportsmenBMJ, 1954